IP Library › Granted Patent US 11,896,505
Granted Patent B2
US 11,896,505 · App. 17/132,493 · Granted Feb 13, 2024

Methods for making and using a structural hydrogel polymer device

Inventor: Scott M. Epstein (Boston, MA)
A61F2/844A61F2/82A61L29/041A61L29/145A61L31/048A61L31/145A61M25/0017A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,896,505
App. No.
17/132,493
Granted
Feb 13, 2024
Kind
B2
Abstract

The present invention relates generally a manufacturing process which results in a completely hydrogel polymer device that maintains lumen patency which allows for numerous applications. One or more physical post-implantation dimensions of the device can be controlled by placing it in a solution that has a predetermined osmolarity and/or pH. In addition, the device can deliver an absorbed therapeutic agent to a target anatomical site. Alternatively, the device can function as a selective membrane to selectively absorb one or more target molecules from a body fluid.

Claims (21)

1. A method for manufacturing a medical device, comprising:

depositing an inner layer material comprising a hydrogel on a rotating, horizontally-disposed mandrel;

coagulating the inner layer material comprising the hydrogel in place on the mandrel;

dehydrating the inner layer material;

depositing a second layer of material comprising a hydrogel on the inner layer material such that the medical device is produced without thermoplastic processing; and

placing the medical device in a solution having a predetermined osmolarity.

2. The method of claim 1 , wherein the predetermined osmolarity is approximately equal to an osmolarity of a target body fluid, whereby one or more physical dimensions of the medical device remains about the same after the medical device is implanted in a target anatomical site that includes the target body fluid.

3. The method of claim 2 , wherein the solution comprises a hypertonic saline solution.

4. The method of claim 3 , wherein the hypertonic saline solution has an NaCl concentration is in a range of about 3.5% NaCl to about 4% NaCl.

5. The method of claim 4 , wherein the target body fluid comprises urine.

6. The method of claim 2 , wherein the one or more physical dimensions comprises an outer diameter of the medical device.

7. The method of claim 1 , wherein the predetermined osmolarity is greater than an osmolarity of a target body fluid, whereby one or more physical dimensions of the medical device increases after the medical device is implanted in a target anatomical site that includes the target body fluid.

8. The method of claim 7 , wherein the solution comprises a hypertonic saline solution having an NaCl concentration in a range of about 4% NaCl to about 5% NaCl.

9. The method of claim 8 , wherein:

the one or more physical dimensions comprises an outer diameter of the medical device, and

the outer diameter increases by about 20% to about 30% after the medical device is implanted in the target anatomical site compared to the outer diameter immediately before the medical device is implanted in the target anatomical site.

10. The method of claim 1 , wherein the predetermined osmolarity is lower than an osmolarity of a target body fluid, whereby one or more physical dimensions of the medical device decreases after the medical device is implanted in a target anatomical site that includes the target body fluid.

11. The method of claim 10 , wherein the solution comprises a saline solution having an NaCl concentration in a range of about 0.1% NaCl to about 2.5% NaCl.

12. The method of claim 11 , wherein:

the one or more physical dimensions comprises an outer diameter of the medical device, and

the outer diameter decreases by about 20% to about 30% after the medical device is implanted in the target anatomical site compared to the outer diameter immediately before the medical device is implanted in the target anatomical site.

Continuity (5)
Continuation In Part 14881753 · Oct 13, 2015
Continuation 13231752 · Sep 13, 2011
Continuation 11590219 · Oct 31, 2006
Provisional Application 60731740 · Oct 31, 2005
Related Publication 20210177630A1 · Jun 17, 2021